Arvind Kush

Insider Reports History

Entity
Individual
Location
C/O Rayzebio, Inc., 5505 Morehouse Drive, Suite 300, San Diego, CA
Signature
/s/ Milton H. Werner, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arvind Kush:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. Director Common Stock 145K $199K $1.37 Oct 21, 2024 Direct
RayzeBio, Inc. CHIEF FINANCIAL OFFICER Common Stock 0 $0 $62.50 Feb 26, 2024 Direct
Inhibikase Therapeutics, Inc. Director Stock Option (right to buy) 60K Oct 21, 2024 Direct
RayzeBio, Inc. CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 0 Feb 26, 2024 Direct

Insider Reports Filed by Arvind Kush

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKT Inhibikase Therapeutics, Inc. Oct 21, 2024 2 $199K 4 Oct 23, 2024 Director
IKT Inhibikase Therapeutics, Inc. Oct 21, 2024 0 $0 3 Oct 23, 2024 Director
RYZB RayzeBio, Inc. Feb 26, 2024 4 -$4.9M 4 Feb 27, 2024 CHIEF FINANCIAL OFFICER
RYZB RayzeBio, Inc. Nov 17, 2023 1 $0 4 Nov 17, 2023 Chief Financial Officer
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 Chief Financial Officer